Interaction of thrombin with antithrombin III and alpha macroglobulin in the plasma

Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.

Thrombosis and haemostasis·1998

Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats.

Thrombosis research·1998

Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.

Neuroscience letters·1998

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

Atherosclerosis·1998

Severe heat stroke associated with high plasma levels of plasminogen activator inhibitor 1.

Burns : journal of the International Society for Burn Injuries·1998

Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II.

Pathology international·1998

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Thrombosis research·2026

Plasma kallikrein in breast cancer cells: Interactions with urokinase plasminogen activator system and syndecans.

Thrombosis research·2026

Risk of cancer after incident venous thromboembolism or cerebral venous thrombosis: Evidence from an Italian administrative healthcare database cohort (2002-2023).

Thrombosis research·2026

Subclinical carotid atherosclerosis in patients with retinal vein occlusion: Differential cardiovascular risk profiles.

Thrombosis research·2026

Clinical and molecular characteristics of hereditary factor XII deficiency in Chinese Han patients: Novel mutations, a high-frequency frameshift variant, and plasma metabolomic profiling.

Thrombosis research·2026

Distinct coagulation-fibrinolysis profiles in traumatic and upper gastrointestinal hemorrhagic shock: Clinical relevance of tPA/PAI-1 complex in traumatic hemorrhagic shock.

Thrombosis research·2026

Vaso-occlusive crisis in the cervicofacial region in sickle cell anemia.

Journal of the American Dental Association (1939)·2026

Mechanisms of Liancao Xueniao Capsules in Treating Hematuria Associated with IgA Nephropathy: Network Pharmacology and Experimental Validation.

Journal of visualized experiments : JoVE·2026

Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis.

Molecular therapy. Nucleic acids·2026

Prognostic role of monocyte-to-high-density lipoprotein ratio in mortality of VTE patients at Ardabil (2023-2024).

Caspian journal of internal medicine·2026

Flatline Thromboelastography During Massive Intraoperative Bleeding in a Patient With Multiple Myeloma: A Case Report.

Cureus·2026

Early antiplatelet therapy was associated with reduced neurological deterioration in stroke patients treated with intravenous thrombolysis.

Brain circulation·2026

Related Experiment Videos

Interaction of thrombin with antithrombin III and alpha macroglobulin in the plasma

Related Concept Videos

Human thrombin and calcium bound factor Xa significantly shorten tPA-induced fibrin clot lysis time via neutralization of plasminogen activator inhibitor type 1 activity.

Effects of electric footshock and water immersion restraint stresses on fibrinolytic parameters in the plasma of rats.

Proteolysis of highly polysialylated NCAM by the tissue plasminogen activator-plasmin system in rats.

Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery.

Severe heat stroke associated with high plasma levels of plasminogen activator inhibitor 1.

Solitary fibrous tumor of the pleura causing recurrent hypoglycemia by secretion of insulin-like growth factor II.

Heparin formulation and thromboprophylaxis intensity in critically ill patients: Results from the ESICM UNITE registry.

Plasma kallikrein in breast cancer cells: Interactions with urokinase plasminogen activator system and syndecans.

Risk of cancer after incident venous thromboembolism or cerebral venous thrombosis: Evidence from an Italian administrative healthcare database cohort (2002-2023).

Subclinical carotid atherosclerosis in patients with retinal vein occlusion: Differential cardiovascular risk profiles.

Clinical and molecular characteristics of hereditary factor XII deficiency in Chinese Han patients: Novel mutations, a high-frequency frameshift variant, and plasma metabolomic profiling.

Distinct coagulation-fibrinolysis profiles in traumatic and upper gastrointestinal hemorrhagic shock: Clinical relevance of tPA/PAI-1 complex in traumatic hemorrhagic shock.

Vaso-occlusive crisis in the cervicofacial region in sickle cell anemia.

Mechanisms of Liancao Xueniao Capsules in Treating Hematuria Associated with IgA Nephropathy: Network Pharmacology and Experimental Validation.

Pharmacological readthrough and base editing for ANK1 nonsense mutations in an erythroid model of hereditary spherocytosis.

Prognostic role of monocyte-to-high-density lipoprotein ratio in mortality of VTE patients at Ardabil (2023-2024).

Flatline Thromboelastography During Massive Intraoperative Bleeding in a Patient With Multiple Myeloma: A Case Report.

Early antiplatelet therapy was associated with reduced neurological deterioration in stroke patients treated with intravenous thrombolysis.

Related Experiment Videos

Interaction of thrombin with antithrombin III and alpha macroglobulin in the plasma

Related Concept Videos

Related Articles